Richard Middleton

2.9k total citations
18 papers, 1.1k citations indexed

About

Richard Middleton is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Richard Middleton has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Richard Middleton's work include Global Cancer Incidence and Screening (6 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Richard Middleton is often cited by papers focused on Global Cancer Incidence and Screening (6 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Richard Middleton collaborates with scholars based in United Kingdom, France and United States. Richard Middleton's co-authors include Howard I. Scher, Michael J. Wehle, Stanley A. Brosman, Mark R. Somerfield, David S. Mendelson, James A. Talcott, Nicholas J. Vogelzang, Gary D. Steinberg, Thomas J. Smith and D.A. Loblaw and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Journal of Cancer.

In The Last Decade

Richard Middleton

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Middleton United Kingdom 11 520 343 313 180 141 18 1.1k
Hedy Mameghan Australia 20 602 1.2× 254 0.7× 415 1.3× 143 0.8× 96 0.7× 54 1.2k
Lawrence R. Ragard United States 13 360 0.7× 253 0.7× 194 0.6× 168 0.9× 59 0.4× 28 1.1k
S. Huan Canada 16 334 0.6× 439 1.3× 383 1.2× 160 0.9× 73 0.5× 36 1.0k
J Bellmunt Spain 14 967 1.9× 751 2.2× 420 1.3× 330 1.8× 57 0.4× 31 1.9k
Thomas L. Riley United States 15 815 1.6× 492 1.4× 199 0.6× 160 0.9× 46 0.3× 27 1.5k
Delphine Amsellem‐Ouazana France 19 568 1.1× 158 0.5× 394 1.3× 553 3.1× 48 0.3× 42 1.4k
Loı̈c Mourey France 16 882 1.7× 565 1.6× 271 0.9× 206 1.1× 101 0.7× 107 1.5k
Guila Delouya Canada 17 498 1.0× 188 0.5× 171 0.5× 98 0.5× 32 0.2× 102 1.1k
Lorne D. Sullivan Canada 19 1.4k 2.7× 415 1.2× 584 1.9× 217 1.2× 349 2.5× 48 2.1k
Darrel Drachenberg Canada 19 773 1.5× 378 1.1× 677 2.2× 438 2.4× 55 0.4× 99 1.5k

Countries citing papers authored by Richard Middleton

Since Specialization
Citations

This map shows the geographic impact of Richard Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Middleton more than expected).

Fields of papers citing papers by Richard Middleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Middleton. The network helps show where Richard Middleton may publish in the future.

Co-authorship network of co-authors of Richard Middleton

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Middleton. A scholar is included among the top collaborators of Richard Middleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Middleton. Richard Middleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Middleton, Richard. (2014). Meeting the psychological care needs of patients with cancer. Nursing Standard. 28(21). 39–45. 10 indexed citations
2.
Gavin, Anna, Brian Rous, Rafael Marcos‐Gragera, et al.. (2014). Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses. European Journal of Cancer. 51(9). 1109–1122. 18 indexed citations
3.
Maringe, Camille, Sarah Walters, John Butler, et al.. (2012). Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership. Gynecologic Oncology. 127(1). 75–82. 157 indexed citations
4.
Boniol, Mathieu, et al.. (2011). Seasonality of cutaneous melanoma diagnosis in Northern Ireland with a review. Melanoma Research. 21(2). 144–151. 14 indexed citations
5.
Napolitano, Giulio, et al.. (2011). Real-time multidisciplinary team meeting management systems. A comparison with paper records for staging completeness and waiting times. Behaviour and Information Technology. 30(4). 473–477. 8 indexed citations
6.
Napolitano, Giulio, et al.. (2010). Pattern-based information extraction from pathology reports for cancer registration. Cancer Causes & Control. 21(11). 1887–1894. 24 indexed citations
7.
Gavin, Anna, et al.. (2009). Cutaneous melanoma mortality starting to change: A study of trends in Northern Ireland. European Journal of Cancer. 45(13). 2360–2366. 29 indexed citations
8.
Loblaw, D.A., Katherine S. Virgo, Robert K. Nam, et al.. (2007). Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline. Journal of Clinical Oncology. 25(12). 1596–1605. 408 indexed citations
9.
Walsh, Paul M., Peter McCarron, Richard Middleton, et al.. (2006). Influence of mammographic screening on trends in breast-conserving surgery in Ireland. European Journal of Cancer Prevention. 15(2). 138–148. 9 indexed citations
10.
Gavin, Anna, Paul A. McCarron, Richard Middleton, et al.. (2004). Evidence of prostate cancer screening in a UK region. British Journal of Urology. 93(6). 730–734. 38 indexed citations
11.
Fitzpatrick, Deirdre, et al.. (2004). Cancer in Northern Ireland 1993-2001: A Comprehensive Report. Research Portal (Queen's University Belfast). 11 indexed citations
12.
Loblaw, D.A., David S. Mendelson, James A. Talcott, et al.. (2004). American Society of Clinical Oncology Recommendations for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer. Journal of Clinical Oncology. 22(14). 2927–2941. 147 indexed citations
13.
Middleton, Richard, et al.. (2003). Ovarian cancer--the need for change in service delivery in Northern Ireland.. PubMed. 72(2). 93–7. 2 indexed citations
14.
Gavin, Anna, Paul Wilkinson, Deirdre Fitzpatrick, et al.. (2003). Lung cancer survival in Northern Ireland.. PubMed. 96(8). 237–40. 2 indexed citations
15.
Steinberg, Gary D., Robert Bahnson, Stanley A. Brosman, et al.. (2000). EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDER. The Journal of Urology. 163(3). 761–767. 246 indexed citations
16.
Steinberg, Gary D., et al.. (2000). EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDER. The Journal of Urology. 761–761. 10 indexed citations
17.
Bahnson, Robert, Stanley A. Brosman, Bruce L. Dalkin, et al.. (1999). EFFECTIVENESS OF VALRUBICIN IN PATIENTS WITH BCG-REFRACTORY CARCINOMA IN SITU OF THE BLADDER. The Journal of Urology. 171–171. 3 indexed citations
18.
Krymkowski, Daniel H. & Richard Middleton. (1987). Social stratification in East Africa: Bases of respect among Kipsigis and Kikuyu men in rural Kenya. Rural Sociology. 52(3). 379–388. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026